Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Innocan Pharma Corporation (TSE:INNO)
:INNO
INNO Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.16 - C$0.33
Previous CloseN/A
Volume118.77K
Average Volume (3M)24.34K
Market Cap
C$51.65M
Enterprise ValueC$60.25M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.10
Next Earnings
Mar 27, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding286,938,260
10 Day Avg. Volume11,558
30 Day Avg. Volume24,343
Standard Deviation0.48
R-Squared0.08
Alpha0.04
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.31
Price to Cash Flow (P/CF)-9.50
P/FCF Ratio0.00
Enterprise Value/Market Cap1.17
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit5.03
Enterprise Value/Ebitda-72.07
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
InnoCan Pharma Corporation News
PremiumCompany Announcements
Innocan Pharma Secures Indian Patent for Liposomal CBD Injection
PremiumCompany Announcements
Innocan Pharma’s Subsidiary Achieves Safety and Sales Milestones
PremiumCompany Announcements
InnoCan Pharma Secures C$635K in Private Placement
PremiumCompany Announcements
Innocan Pharma Announces C$700K Private Placement
PremiumCompany Announcements
InnoCan Pharma Achieves Key Milestones in 2024PremiumCompany Announcements
Innocan Pharma Reports Positive Safety Results---
Options Prices
Currently, No data available
---
Ownership Overview
INNO FAQ
What was Innocan Pharma Corporation’s price range in the past 12 months?
Innocan Pharma Corporation lowest stock price was C$0.16 and its highest was C$0.33 in the past 12 months.
What is Innocan Pharma Corporation’s market cap?
Innocan Pharma Corporation’s market cap is C$51.65M.
When is Innocan Pharma Corporation’s upcoming earnings report date?
Innocan Pharma Corporation’s upcoming earnings report date is Mar 27, 2025 which is in 35 days.
How were Innocan Pharma Corporation’s earnings last quarter?
Innocan Pharma Corporation released its earnings results on Nov 20, 2024. The company reported -C$0.001 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.001.
Is Innocan Pharma Corporation overvalued?
According to Wall Street analysts Innocan Pharma Corporation’s price is currently Overvalued.
Does Innocan Pharma Corporation pay dividends?
Innocan Pharma Corporation does not currently pay dividends.
What is Innocan Pharma Corporation’s EPS estimate?
Innocan Pharma Corporation’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Innocan Pharma Corporation have?
Innocan Pharma Corporation has 286,938,260 shares outstanding.
What happened to Innocan Pharma Corporation’s price movement after its last earnings report?
Innocan Pharma Corporation reported an EPS of -C$0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 4.762%.
Which hedge fund is a major shareholder of Innocan Pharma Corporation?
Currently, no hedge funds are holding shares in TSE:INNO
---
Company Description
Innocan Pharma Corporation
InnoCan Pharma Corp is a Canada based company engaged in the research, development, marketing, distribution and sales of InnoCan-branded OTC pharmaceutical products. Its brands include Shir and Relief & Go.
---
Technical Analysis
---